The New England Journal Of Medicine Publishes Two Landmark Studies Of NOXAFIL(R) (Posaconazole) In The Prevention Of Invasive Fungal Infections

... Two landmark clinical studies demonstrating the efficacy of NOXAFIL(R) (posaconazole) Oral Suspension in the prevention (prophylaxis) of life-threatening invasive fungal infections (IFIs) caused by Aspergillus and Candida in high-risk patients were published today in The New England Journal of Medicine,(1,2) reported Schering-Plough Corporation (NYSE: SGP). [click link for full article] ...